Results 251 to 260 of about 336,398 (336)
A CRISPR‐free mitochondrial RNA m1A demethylation (MRD) editor combining MTS, PUF proteins, and ALKBH3 enables precise m1A removal from mitochondrial mRNA and tRNA, which influences mitochondrial protein levels, cellular proliferation, ATP production, and mitochondrial respiration. Subsequently, in vivo demethylation of the m1A modification is achieved
Xiangrui Li +13 more
wiley +1 more source
MRAS: Master Regulator Analysis of Alternative Splicing. [PDF]
Zhou L +9 more
europepmc +1 more source
Activated tumor‐intrinsic cyclin D1‐CDK4/6 signaling attenuates lymphocyte infiltration, and consequently, and immunotherapy resistance in HNSCC. It is discovered that brief CDK4/6i priming before anti‐PD‐1 results in enhanced durability of ICB response durability through Stat5a+ progenitor exhausted CD8+ T cells induced by IL15‐secreted Sell(hi ...
Yu Zhang +13 more
wiley +1 more source
Nup93-Mediated RNA Alternative Splicing Associated With Diabetic Atherosclerosis. [PDF]
Yuan X +5 more
europepmc +1 more source
Snol, a novel alternatively spliced isoform of the ski protooncogene homolog, sno [PDF]
Sonia Pearson‐White
openalex +1 more source
This study presents the sono‐sensitive nanorobot Sono@NAT10, which targets NAT10 condensates to reprogram tumor‐associated macrophages in colorectal cancer. By reducing the acetylation level of SRSF2 protein and activating HDAC10, Sono@NAT10 promotes M1 polarization, suppresses tumor progression, and strengthens immunotherapy. The approach demonstrates
Jiahao Zhu +11 more
wiley +1 more source
Systematic Analysis of Alternative Splicing in Transcriptomes of Multiple Sclerosis Patient Brain Samples. [PDF]
Sak M, Chariker JH, Rouchka EC.
europepmc +1 more source

